Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Pneumococcal Vaccination Status for Older Adults

Compare Versions of: "Pneumococcal Vaccination Status for Older Adults"

The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.

Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.

Compare version to

Table Options
Measure Information 2022 Performance Period 2023 Performance Period
Title Pneumococcal Vaccination Status for Older Adults Pneumococcal Vaccination Status for Older Adults
CMS eCQM ID CMS127v10 CMS127v11
CBE ID* Not Applicable Not Applicable
MIPS Quality ID 111 111
Measure Steward National Committee for Quality Assurance National Committee for Quality Assurance
Description

Percentage of patients 66 years of age and older who have ever received a pneumococcal vaccine

Percentage of patients 66 years of age and older who have received a pneumococcal vaccine

Measure Scoring Proportion measure Proportion measure
Measure Type Process Process
Stratification *See CMS127v10.html *See CMS127v11.html
Risk Adjustment *See CMS127v10.html *See CMS127v11.html
Rationale *See CMS127v10.html *See CMS127v11.html
Clinical Recommendation Statement *See CMS127v10.html *See CMS127v11.html
Improvement Notation

Higher score indicates better quality

Higher score indicates better quality

Definition *See CMS127v10.html *See CMS127v11.html
Guidance

Patient self-report for procedures as well as immunizations should be recorded in 'Procedure, Performed' template or 'Immunization, Administered' template in QRDA-1.

This eCQM is a patient-based measure.

This version of the eCQM uses QDM version 5.5. Please refer to the eCQI resource center for more information on the QDM.

This eCQM is a patient-based measure.

This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM.

Initial Population

Patients 66 years of age and older with a visit during the measurement period

Patients 66 years of age and older at the start of the measurement period with a visit during the measurement period

Denominator

Equals Initial Population

Equals Initial Population

Denominator Exclusions

Exclude patients who are in hospice care for any part of the measurement period.

Exclude patients who are in hospice care for any part of the measurement period

Numerator

Patients who received a pneumococcal vaccination on or after their 60th birthday and before the end of the measurement period; or ever had an adverse reaction to the vaccine before the end of the measurement period

Patients who received a pneumococcal vaccination on or after their 60th birthday and before the end of the measurement period

Numerator Exclusions

Not Applicable

Not Applicable

Denominator Exceptions

None

None

Telehealth Eligible Yes Yes
Next Version No Version Available
Previous Version No Version Available

There is a known issue on CMS127v10. See issue EKI-14 on the ONC eCQM Known Issues Dashboard for details.

Header

  • Updated the eCQM version number.

    Measure Section: eCQM Version Number

    Source of Change: Annual Update

  • Revised the age in the description to align with updates limiting the numerator to the PPSV23 vaccine.

    Measure Section: Description

    Source of Change: Measure Lead

  • Updated copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • Updated the rationale to align with current evidence.

    Measure Section: Rationale

    Source of Change: Measure Lead

  • Updated the clinical recommendation statement to align with current clinical recommendations.

    Measure Section: Clinical Recommendation Statement

    Source of Change: Measure Lead

  • Updated references.

    Measure Section: Reference

    Source of Change: Annual Update

  • Updated the guidance to clarify the measure intent and support implementation.

    Measure Section: Guidance

    Source of Change: Measure Lead

  • Revised the age in the initial population to align with updates limiting the numerator to the PPSV23 vaccine.

    Measure Section: Initial Population

    Source of Change: Measure Lead

  • Replaced 'overlaps' or 'overlapping' in the denominator exclusions with plain language to clarify the measure intent.

    Measure Section: Denominator Exclusions

    Source of Change: Measure Lead

  • Revised the numerator statement to align with the clinical recommendations related to age and adverse reactions.

    Measure Section: Numerator

    Source of Change: Measure Lead

Logic

  • Added online assessments and telephone visits as appropriate encounters based on the increased use of telehealth services.

    Measure Section: Initial Population

    Source of Change: Measure Lead

  • Revised the age in the Initial Population definition to align with updates limiting the numerator to the PPSV23 vaccine.

    Measure Section: Initial Population

    Source of Change: Measure Lead

  • Revised the Numerator definition and added two definitions, Has Pneumococcal Polysaccharide Vaccine 23 Administered and Has Pneumococcal Vaccine Adverse Reaction, to align with the clinical recommendations related to age and adverse reactions.

    Measure Section: Numerator

    Source of Change: Measure Lead

  • Updated the version number of the Measure Authoring Tool (MAT) Global Common Functions Library (MATGlobalCommonFunctions-6.2.000). Updated the 'Inpatient Encounter' definition to include a 'day of' timing clarification. Added the following timing functions: Normalize Interval, Has Start, Has End, Latest, Latest Of, Earliest, and Earliest Of. Please see individual measure details for application of specific timing functions.

    Measure Section: Multiple Sections

    Source of Change: Standards Update

  • Added new NormalizeInterval function to timing attributes to decrease implementation burden due to variable use of timing attributes for select QDM data types. The NormalizeInterval function was applied, where applicable, for the following data elements: Assessment, Performed; Device, Applied; Diagnostic Study, Performed; Intervention, Performed; Laboratory Test, Performed; Medication, Administered; Medication, Dispensed; Physical Exam, Performed; Procedure, Performed; Substance, Administered.

    Measure Section: Multiple Sections

    Source of Change: Standards Update

  • Updated Hospice CQL Library to version 3.0.000.

    Measure Section: Multiple Sections

    Source of Change: Measure Lead

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

  • Added value set Telephone Visits (2.16.840.1.113883.3.464.1003.101.12.1080) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added value set Online Assessment (2.16.840.1.113883.3.464.1003.101.12.1089) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added direct reference codes CPT codes (90732, 99211) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Added direct reference code SNOMED CT code (293116002) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Replaced value set Pneumococcal Vaccine Administered (2.16.840.1.113883.3.464.1003.110.12.1034) with value set Pneumococcal Polysaccharide 23 Vaccine (2.16.840.1.113883.3.464.1003.110.12.1089) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

Last Updated: Jun 03, 2024